click on the image above to watch the webcast
(to view the webcast in fullscreen, click on the bottom right square icon underneath the YouTube logo)

In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about will blood monitoring become a reliable and practical method with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Maria Victoria Mateos (University of Salamanca, Spain).

This video is the fifth in a six-part series that focuses on making sense of multiple myeloma treatment based upon the newly obtained input from the American Society of Hematology (ASH) 60th annual convention which took place in San Diego, CA on December 2018.

click here to download slides (https://s3.us-west-1.wasabisys.com/imf-d8-prod/pdfs/ash18_imwgconfseries_duriemikhaelmateos_v2.pdf)

Other Topics:

• Bispecific T-cell Engagers (BiTEs) (https://www.myeloma.org/node/1488)
• CAR T-cell Therapy (https://www.myeloma.org/node/1487)
• Frontline Therapy (https://www.myeloma.org/node/1486)
• Maintenance (https://www.myeloma.org/node/1485)
• Blood Monitoring (https://www.myeloma.org/node/1484)
• MRD in Relapse (https://www.myeloma.org/node/1483)

We thank supporters of this program:
Celgene Corporation, Karyopharm Therapeutics, and Takeda Oncology